Plancorp LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Plancorp LLC’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-4,241	Closed	-$224K	–	111
2014 Q1	$224K	Buy	+4,241	New	+$196K	0.15%	100

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Plancorp LLC's TEVA Position: Q2 2014 in Review

Plancorp LLC sold out of Teva Pharmaceuticals (TEVA) in Q2 2014, closing a stake of 4,241 shares — an estimated $224K sold.

Plancorp LLC first reported a position in TEVA in Q1 2014 and held it in 1 quarter. The position peaked at $224K in Q1 2014. 779 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

Plancorp LLC reported no remaining Teva Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Plancorp LLC sold 4,241 Teva Pharmaceuticals shares in Q2 2014, an estimated $224K.
Plancorp LLC first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 1 quarter.
Plancorp LLC's Teva Pharmaceuticals position peaked at $224K in Q1 2014.
779 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2014.

Based on Plancorp LLC's 13F filing for Q2 2014, filed 11 Aug 2014.